Atlas Trials

Impact of Peptides and Chelators on Somatostatin Receptor Antagonists

Clinical trial NCT04491851 · UNKNOWN

Trial details

NCT number
NCT04491851
Sponsor
Peking Union Medical College Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Neuroendocrine Tumors
Start date
2020-10-01
Primary completion
2021-09-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.